XML 53 R42.htm IDEA: XBRL DOCUMENT v3.8.0.1
Business Segments (Details) - USD ($)
$ in Thousands
 3 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Jun. 30, 2017
Segment Reporting Information [Line Items]      
Net sales $ 193,412 $ 187,987  
Depreciation and amortization 6,644 6,318  
Adjusted EBITDA - Total segments 37,706 37,349  
Reconciliation of income before income taxes to Adjusted EBITDA      
Income before income taxes 18,944 17,572  
Interest expense, net (3,118) (3,907)  
Depreciation and amortization 6,644 6,318  
Acquisition-related accrued compensation 437 420  
Foreign currency (gains) losses, net 325 334  
Adjusted EBITDA - Total segments 37,706 37,349  
Identifiable assets 671,111   $ 623,397
Operating Segments      
Segment Reporting Information [Line Items]      
Net sales 193,412 187,987  
Depreciation and amortization 6,085 5,658  
Adjusted EBITDA - Total segments 37,706 37,349  
Reconciliation of income before income taxes to Adjusted EBITDA      
Income before income taxes 18,944 17,572  
Interest expense, net 3,118 3,907  
Depreciation and amortization 6,085 5,658  
Acquisition-related cost of goods sold 249    
Acquisition-related accrued compensation 437 420  
Acquisition-related transaction costs 400 1,274  
Foreign currency (gains) losses, net 325 334  
Adjusted EBITDA - Total segments 37,706 37,349  
Identifiable assets 561,777   521,386
Operating Segments | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 128,841 124,501  
Depreciation and amortization 5,254 4,898  
Adjusted EBITDA - Total segments 33,742 32,619  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 5,254 4,898  
Adjusted EBITDA - Total segments 33,742 32,619  
Identifiable assets 479,075   442,521
Operating Segments | Mineral Nutrition      
Segment Reporting Information [Line Items]      
Net sales 52,073 51,592  
Depreciation and amortization 585 542  
Adjusted EBITDA - Total segments 3,716 3,988  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 585 542  
Adjusted EBITDA - Total segments 3,716 3,988  
Identifiable assets 60,371   55,184
Operating Segments | Performance Products      
Segment Reporting Information [Line Items]      
Net sales 12,498 11,894  
Depreciation and amortization 246 218  
Adjusted EBITDA - Total segments 248 742  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 246 218  
Adjusted EBITDA - Total segments 248 742  
Identifiable assets 22,331   23,681
Operating Segments | MFAs and other | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 79,603 83,419  
Operating Segments | Nutritional specialties | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 30,777 26,304  
Operating Segments | Vaccines | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 18,461 14,778  
Corporate      
Segment Reporting Information [Line Items]      
Depreciation and amortization 559 660  
Adjusted EBITDA - Total segments 7,589 7,524  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 559 660  
Adjusted EBITDA - Total segments 7,589 $ 7,524  
Identifiable assets $ 109,334   $ 102,011